- Home
- SSL vs ACLX Comparison
SSL vs ACLX Comparison
Compare SSL & ACLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SSL
- ACLX
- Stock Information
- Founded
- SSL 1950
- ACLX 2015
- Country
- SSL South Africa
- ACLX United States
- Employees
- SSL N/A
- ACLX N/A
- Industry
- SSL Oil & Gas Production
- ACLX Biotechnology: Pharmaceutical Preparations
- Sector
- SSL Energy
- ACLX Health Care
- Exchange
- SSL Nasdaq
- ACLX Nasdaq
- Market Cap
- SSL 4.0B
- ACLX 4.4B
- IPO Year
- SSL N/A
- ACLX 2022
- Fundamental
- Price
- SSL $6.88
- ACLX $89.53
- Analyst Decision
- SSL
- ACLX Strong Buy
- Analyst Count
- SSL 0
- ACLX 9
- Target Price
- SSL N/A
- ACLX $117.78
- AVG Volume (30 Days)
- SSL 1.3M
- ACLX 384.8K
- Earning Date
- SSL 01-01-0001
- ACLX 11-05-2025
- Dividend Yield
- SSL N/A
- ACLX N/A
- EPS Growth
- SSL N/A
- ACLX N/A
- EPS
- SSL 0.59
- ACLX N/A
- Revenue
- SSL $14,028,282,389.00
- ACLX $35,898,000.00
- Revenue This Year
- SSL $1.50
- ACLX N/A
- Revenue Next Year
- SSL $6.56
- ACLX $220.95
- P/E Ratio
- SSL $11.28
- ACLX N/A
- Revenue Growth
- SSL N/A
- ACLX N/A
- 52 Week Low
- SSL $2.78
- ACLX $47.86
- 52 Week High
- SSL $7.25
- ACLX $107.37
- Technical
- Relative Strength Index (RSI)
- SSL 64.48
- ACLX 58.26
- Support Level
- SSL $6.13
- ACLX $84.50
- Resistance Level
- SSL $6.40
- ACLX $90.30
- Average True Range (ATR)
- SSL 0.17
- ACLX 3.88
- MACD
- SSL 0.09
- ACLX -0.24
- Stochastic Oscillator
- SSL 92.65
- ACLX 72.51
About SSL Sasol Ltd.
Sasol Ltd operates as a vertically integrated chemicals and energy company through its two main businesses: the Southern Africa Energy & Chemicals business and the International Chemical business. It generates maximum revenue from the Southern Africa Energy & Chemicals business, which operates integrated value chains with feedstock sourced from the Mining and Gas operating segments. Geographically, the company generates the majority of its revenue from South Africa.
About ACLX Arcellx Inc.
Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.